In the BioHarmony Drug Report Database

"Preview" Icon

Fluticasone propionate

Armonair Digihaler, Armonair Respiclick, Cutivate, Flonase, Flonase Relief, Flovent, Flovent Diskus, Flovent Hfa, Xhance, BroPair Spiromax, Seffalair Spiromax (fluticasone propionate) is a small molecule pharmaceutical. Fluticasone propionate was first approved as Armonair Digihaler on 1990-12-14. It is used to treat allergic rhinitis perennial in the USA. It has been approved in Europe to treat asthma. The pharmaceutical is active against glucocorticoid receptor. In addition, it is known to target mineralocorticoid receptor and progesterone receptor. Advair diskus’s patents are valid until 2038-12-18 (FDA).


Trade Name


BroPair Spiromax, Seffalair Spiromax

Common Name


fluticasone propionate






allergic rhinitis perennial, asthma

Drug Class


Steroids and steroid derivatives

Image (chem structure or protein)

Fluticasone propionate structure rendering